Thrombolytic Drugs Current Events | Thrombolytic Drugs News
|
| Page
1 of
22 |
434 Results |
|
|
|
Sort By:
Page Views | Date |
Treatment window expanded
Patients can still benefit up to 4.5 hours after a stroke if a drug that dis-solves blood clots in the brain is administered. Thus far, three hours had been considered the useful limit for administering thrombolytic drugs. view more (2008-10-01)
Patients who wake up with stroke may be candidates for clot-busters
Giving clot-busting drugs to patients who wake up with stroke symptoms appears to be as safe as giving it to those in the recommended three-hour window, according to researchers at The University of Texas Medical School at Houston. view more (2009-03-13)
Stroke therapy window might be extended past nine hours for some
Some patients who suffer a stroke as a result of a blockage in an artery in the brain may benefit from a clot-busting drug nine or more hours after the onset of symptoms. The findings are published in the online edition of Radiology. view more (2009-02-09)
Portable CT increases chance of stroke survival and recovery
New research has found that the availability of a portable eight-slice computed tomography (CT) scanner in an emergency room can significantly increase the number of stroke victims who receive a potentially life-saving treatment. view more (2008-12-02)
ESC Congress 2003: Sudden cardiac death - New drug therapies improve outcome
IMPORTANT: This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology ESC Congress 2003: Cold comfort - cough for your life Sudden cardiac death is mostly... view more... (2003-09-02)
ANGIOPLASTY OR MEDICAL THERAPY IMMEDIATELY AFTER HEART ATTACK? (p 814, 825 )
Authors of a study in this week’s issue of THE LANCET suggest that there is no difference in treatment outcome of pre-hospital medical therapy with anti-clotting drugs or emergency angioplasty after severe heart attack. Although the use of anti-clotting drugs before hospital admission (prehospital fibrinolysis) and primary angioplasty... view more... (2002-09-11)
UGA study suggests that lowering blood pressure following stroke may reduce damage
A new University of Georgia study suggests that commonly prescribed drugs used to lower blood pressure may help reduce brain damage when given within 24 hours of a stroke. view more (2007-04-18)
Aspirin and similar drugs may be associated with brain microbleeds in older adults
Individuals who take aspirin or other medications that prevent blood clotting by inhibiting the accumulation of platelets appear more likely to have tiny, asymptomatic areas of bleeding in the brain. view more (2009-04-14)
ESC Congress 2003: Different outcomes in patients suffering from heart attacks among countries with different Gross National Income
IMPORTANT: This press release accompanies a poster or oral session given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology ESC Congress 2003: Recent publications suggested different outcomes in patients admitted to hospitals with... view more... (2003-09-01)
Morphochem Signs Deal With AstraZeneca To Develop Novel Anti-thrombotics
Munich, November 21st 2002 "¦. Morphochem AG, a leader in evolutionary discovery of small molecule drugs, has entered into a research collaboration with AstraZeneca AB (Sweden) wherein Morphochem will apply its drug discovery engine, the MOREsystem™, to the discovery of compounds with novel structures with activity against an... view more... (2002-11-21)
New-generation Antipsychotic Drugs May Have Similar Neurological Side-effects To Conventional Drugs (p 1581)
Authors of a systematic review of antipsychotic drugs in this week's issue of THE LANCET highlight how the better side-effect profile of new-generation drugs may not be as substantial as previously thought when compared with conventional antipsychotics. New-generation drugs are generally more efficacious, although older-generation antipsychotics... view more... (2003-05-07)
Sleep attacks from Parkinson`s drugs do exist
Car crashes in patients with Parkinson’s disease have been associated with sudden sleep attacks caused by dopamine drugs, but the concept of sleep attacks, and their connection with dopamine drugs, has been disputed. view more (2002-06-19)
Study supports triple combination therapy for HIV
New evidence in this week’s BMJ supports the use of up to three antiviral drugs (triple therapy) to treat people with HIV. view more (2002-03-27)
Pricey new versions of old drugs fuelling huge rise in drug spending
Newly patented versions of old drugs are driving the rapid growth in expenditure on prescription drugs in most developed countries, without offering substantial improvements over existing products, finds a study published online by the BMJ today. view more (2005-09-02)
Bisphosphonate drugs reduce the risk of broken bones in breast cancer patients
Bisphosphonate drugs reduce the risk of bone complications when used in patients whose cancer has spread to the bone, according to a new study in the BMJ. view more (2003-08-29)
Moms, have you done drugs? Tell your kids
Moms who have used drugs may be doing their teens a favour by admitting to it, University of Alberta research shows. view more (2009-06-10)
Over 6% of admissions to one unit related to pharmaceutical drugs; and over two thirds avoidable
More than 6% of admissions to one medical unit over six months were related to pharmaceutical drugs, reveals a study in Quality and Safety in Health Care. And over two thirds of these cases were potentially avoidable, concludes the research. view more (2003-08-01)
Biotechnology has failed to live up to its promises
Promises of cheaper and better drugs using biotechnologies have not been met, say researchers in this week's BMJ. view more (2005-10-14)
Vernalis plc: Research and Development Update
Vernalis plc (LSE: VER, NASDAQ: VNLS) is today providing to sector analysts a comprehensive update on in its R&D pipeline. Highlights include: Frovatriptan A Phase III long-term safety study has been initiated to support the extension of frovatriptan's approved use to the prevention of menstrually-associated migraine. A confirmatory Phase III... view more... (2003-11-27)
Fighting drug-resistant flu viruses
Amid reports that swine flu viruses are developing the ability to shrug off existing antiviral drugs, scientists in Japan are reporting a first-of-its kind discovery that could foster a new genre of antivirals that sidestep resistance problems. view more (2009-07-15)
|
|
| Page
1 of
22 |
434 Results |
|
|
|
Sort By:
Page Views | Date |
|
